Bausch Health’s lotion for plaque psoriasis wins FDA approvalApprovals, Consultants, FDA, FDA/Regulatory, Forecasts, Lotions, Pharmacokinetic Data, Plaque, Plaque Psoriasis, Red LesionsThe U.S. Food and Drug Administration approved Bausch Health Companies Inc.’s topical plaque psoriasis treatment Duobrii, which is expected to be a key revenue driver for the company. Read more April 25, 2019/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2019-04-25 14:22:332019-04-26 12:47:22Bausch Health’s lotion for plaque psoriasis wins FDA approval